RBBP4 Enhances Platinum Chemo Resistance in Lung Adenocarcinoma

RBBP4 Enhances Platinum Chemo Resistance in Lung Adenocarcinoma

Background. The majority of lung cancers are adenocarcinomas, with the proportion being 40%. The patients are mostly diagnosed in the middle and late stages with metastasis and easy recurrence, which poses great challenge to the treatment and prognosis. Platinum-based chemotherapy is a primary treat...

Full description

Bibliographic Details
Main Authors: Nianwu Wang, Wei Wang, Wenli Mao, Nazuke Kuerbantayi, Nuan Jia, Yan Chen, Fang Zhou, Li Yin, Yukun Wang
Format: Article
Language:English
Published: Hindawi Limited 2021-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2021/6905985

Similar Items

Similar Items